Conclusion: Our study defined the pro-oncogenic role of AFP in HCC progression and uncovered a novel antiapoptotic mechanism connecting AFP to HuR-mediated Fas translation. The gene discussed is ELAVL1; the disease is hepatocellular carcinoma.